Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Philippe Goupille, Zenas Z N Yiu et al.|JAMA Network Open|2021Cited by 117
Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID RegistryC. A. Isnardi, César Graf, Karen Roberts et al.|Clinical Rheumatology|2022Cited by 21